|
|
Volumn 8, Issue 5, 2009, Pages 349-
|
|
NR2B antagonist pursued for treatment-resistant depression.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINO ACID RECEPTOR BLOCKING AGENT;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NEW DRUG;
NR2B NMDA RECEPTOR;
DRUG ANTAGONISM;
HUMAN;
MAJOR DEPRESSION;
METHODOLOGY;
NOTE;
PHASE 2 CLINICAL TRIAL;
PSYCHOLOGICAL ASPECT;
TREATMENT OUTCOME;
CLINICAL TRIALS, PHASE II AS TOPIC;
DEPRESSIVE DISORDER, MAJOR;
DRUGS, INVESTIGATIONAL;
EXCITATORY AMINO ACID ANTAGONISTS;
HUMANS;
RECEPTORS, N-METHYL-D-ASPARTATE;
TREATMENT OUTCOME;
|
|
EID: 65549102017
PISSN: None
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2880 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|